GREGORY GARNER: Open Payments
NPI 1326215633 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$380 in 16 payments from 7 companies in 2025. Trend: 2023 $14 · 2024 $262 · 2025 $380
Food & beverage: $363Entertainment: $16
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 8 | $228 |
| Merck Sharp & Dohme LLC | 2 | $48 |
| Exact Sciences Corporation | 2 | $37 |
| Janssen Pharmaceuticals, Inc | 1 | $21 |
| Optos, Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $16 |
| Novartis Pharmaceuticals Corporation | 1 | $14 |
Products named: Yeztugo, PIFELTRO, Cologuard Collection Kit, SPRAVATO, Biktarvy, NFC-700, MOUNJARO, LEQVIO.
Industry payments across LA — which companies pay providers there.
